Professionally managed pharmaceutical and health news website. Our news feed is from reliable sources on which we can depend on and spread forward for more awareness. Someone said "information is power" and we are here to use this information to further educate the mankind so that they can use this information to make a better-informed judgment. Wishing you all the best from www.genericmedicine.com
Friday, June 29, 2018
IL-1 blockade with canakinumab reduces gout flares
Treatment with the immunomodulatory agent canakinumab reduces the risk of gout flares by more than half in patients with atherosclerosis, according to a post hoc analysis of the CANTOS* trial.